Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ANTIBODIES, MONOCLONAL, HUMANIZED - ECONOMICS , . Treffer: 3

2017

Kandolf Sekulovic, L; Peris, K; Hauschild, A; Stratigos, A; Grob, JJ; Nathan, P; Dummer, R; Forsea, AM; Hoeller, C; Gogas, H; Demidov, L; Lebbe, C; Blank, C; Olah, J; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Hansson, J; Rutkowski, P; Krajsova, I; Bylaite-Bucinskiene, M; Zalaudek, I; Maric-Brozic, J; Babovic, N; Banjin, M; Putnik, K; Weinlich, G; Todorovic, V; Kirov, K; Ocvirk, J; Zhukavets, A; Kukushkina, M; De La Cruz Merino, L; Ymeri, A; Risteski, M; Garbe, C More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Eur J Cancer. 2017; 75(4):313-322
Web of Science PubMed FullText FullText_MUG

 

2013

Resch, B; Michel-Behnke, I Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumab.
Curr Opin Cardiol. 2013; 28(2):85-91
Web of Science PubMed FullText FullText_MUG

 

2012

Resch, B; Sommer, C; Nuijten, MJ; Seidinger, S; Walter, E; Schoellbauer, V; Mueller, WD Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria.
PEDIATR INFECT DIS J. 2012; 31(1): e1-e8.
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum